Parkinson's disease and microRNAs - Lessons from model organisms and human studies
- 8 October 2021
- journal article
- review article
- Published by Elsevier in Experimental Gerontology
- Vol. 155, 111585
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R15 AG051132-01)
This publication has 194 references indexed in Scilit:
- The C. elegans MicroRNA mir-71 Acts in Neurons to Promote Germline-Mediated Longevity through Regulation of DAF-16/FOXOCell Metabolism, 2012
- MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9AGE, 2011
- miRNA response to DNA damageTrends in Biochemical Sciences, 2011
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- MicroRNAs Both Promote and Antagonize Longevity in C. elegansCurrent Biology, 2010
- MicroRNA Functions in Stress ResponsesMolecular Cell, 2010
- Behavioral phenotyping of mouse models of Parkinson's diseaseBehavioural Brain Research, 2010
- A critical evaluation of the ubiquitin–proteasome system in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Integrating the stress response: lessons for neurodegenerative diseases from C. elegansTrends in Cell Biology, 2009
- Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-SynucleinThe American Journal of Human Genetics, 2008